Subcutaneous Heparin in the Treatment of Interstitial Cystitis
- 1 January 1985
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Urology and Nephrology
- Vol. 19 (1) , 27-29
- https://doi.org/10.3109/00365598509180218
Abstract
Chronic interstitial cystitis (IC) is an inflammatory condition of the bladder of unknown aetiology. Clinically, IC is difficult to handle. Previously, we reported that administration of subcutaneous heparin has an immediate, ameliorating effect. We have now followed eight of the patients for one year or more, during which period they received subcutaneous heparin in doses varying from 5000 IU per day to 5000 IU 2–3 times a week. This treatment was found to have a long-term beneficial effect. No side effects were observed.This publication has 12 references indexed in Scilit:
- Histamine Content and Mast Cell Count of Detrusor Muscle in Patients with Interstitial Cystitis and Other Types of Chronic CystitisBritish Journal of Urology, 1983
- Successful Treatment of Interstitial Cystitis with Sodium pentosanpolysulfateJournal of Urology, 1983
- Chronic Interstitial Cystitis: Increased Levels of Eosinophil Cationic Protein in Serum and Urine and an Ameliorating Effect of Subcutaneous HeparinScandinavian Journal of Urology and Nephrology, 1983
- Mast Cells in Interstitial CystitisBritish Journal of Urology, 1982
- Interstitial Cystitis as an Autoimmune DiseaseEuropean Urology, 1980
- The anti-inflammatory action of heparin: Heparin as an antagonist to histamine, bradykinin and prostaglandin E1Thrombosis Research, 1979
- Endogenous HeparinSeminars in Thrombosis and Hemostasis, 1978
- Large Burns in HumansPublished by American Medical Association (AMA) ,1973
- Fibrinolytic activity of reparative connective tissueThe Journal of Pathology and Bacteriology, 1964
- Recent Concepts of Interstitial CystitisJournal of Urology, 1963